Podcast: Play in new window | Download (Duration: 4:44 — 10.8MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 31 of Biotalk, Geoff Meyerson, CEO of Locust Walk, explores Asia-Pacific biotech momentum across China, Japan, and Korea, as featured […]
Podcast: Play in new window | Download (Duration: 13:18 — 30.4MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 30 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q3 Report: Global Trends in Biopharma
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2025 Q3 Report applies the latest data to analyze the current landscape in life sciences deals.
Thoughts from Geoff Meyerson This past two weeks I had the privilege of visiting Japan and China, hosted by Locust
LOCUST WALK NEWS Bausch Health to Acquire DURECT Corporation DURECT’s lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough
Podcast: Play in new window | Download (Duration: 7:34 — 17.3MB)
Subscribe: Apple Podcasts | Spotify | RSS
During the Asia-focused Episode 29 of Biotalk, Geoff shares insights into key trends and developments shaping the biotech landscapes in
Podcast: Play in new window | Download (Duration: 17:28 — 40.0MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 28 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q2 Report: Global Trends in Biopharma
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2025 Q2 Report applies the latest data to analyze the current landscape in life sciences deals.
Podcast: Play in new window | Download (Duration: 7:47 — 17.8MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 27 of Biotalk, Geoff Meyerson, CEO of Locust Walk, steps back to examine the macro forces shaping the